Who we are
Advancing Eye Research That Changes Lives.
Australian Vision Research (AVR) is a not-for-profit organisation dedicated to promoting and supporting research into the causes of eye disease and the prevention of blindness.
We are:
- An incorporated company limited by guarantee
- Recognised as a Health Promotion Charity (HPC) by the ACNC
- Endorsed as a Deductible Gift Recipient (DGR), meaning donations to AVR are tax-deductible


What we Fund
AVR supports research into all major eye diseases.
Each year, we distribute research grants funded through generous donations and bequests, often from individuals whose own sight has been saved thanks to advances in eye care.
If you’d like to support the fight against eye disease, join our donors.
5 Year Strategic Plan 2022 – 2027
Growing funding and support for research
- Grow our financial capital and reserves.
- Build research capacity through increasing grant value and numbers and support for applicants.
- Develop a fundraising program
including appointing a fundraising coordinator to manage bequests, donations, government grants and partnerships. - Establish and nurture corporate sponsorship.
- Create brand collateral to support AVR’s activities.
- Establish a CRM to manage stakeholder communication.
Growing our engagement
- Improve our communication across channels with targeted content.
- Establish new membership categories.
- Report on our successes by publishing stories of grant recipients and member achievements.
- Upskill members on research methodology and writing grant applications.
- Develop and enhance digital interactions for members.
- Grow our engagement with RANZCO fellows.
- Grow our engagement with patients and have an active dialogue with consumers.
Growing our impact and reach
- Establish an engagement plan for stakeholder groups and strategic partners.
- Collaborate on whitepapers and thought leadership articles.
- Dialogue with federal and state bodies and engagement on key issues in alignment with key partners.
- Advocate for evidence- based eye care.
- Collaborate with RANZCO and ANZEF on joint initiatives.
- Support the next generation of eye researchers and, in partnership with RANZCO, clinician scientists.
- Measure and report on the impact of our funding.
Continuous Improvement
Continually improving our governance and sustainability in alignment with best practices:
- Restructure the board to include skills-based non-executive directors.
- Ensure that our financial accounting follows best practice, is up-to-date, reconciled, and able to produce accurate reporting.
- Establish a risk management plan and register to ensure adequate internal controls and risk identification and mitigation.
- Review policies, committee charters and structures every two years.
- Maintain our ASIC, ACNC and Health Promotion Charity registration.
Grant Eligiability
Partnerships that elevates research.
To foster collaboration and uphold excellence, all AVR-funded projects must include at least one investigator who is a Fellow of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO).
This requirement connects each project to clinical expertise and ensures the research stays grounded in real-world impact.
Our Impact
AVR supports research into all major eye diseases.
AVR funding has a multiplier effect of at least 10x, enabling researchers to go on and secure larger grants through bodies like the NHMRC and ARC.
Our Priming Grants (formerly New Investigator Grants) have launched the careers of early-stage RANZCO Fellows who now lead vital work in research, policy, and advocacy across Australia, New Zealand, and the Asia-Pacific region.
Research Type Distribution
Specialities Funded
Equality
>$14.5M invested in ophthalmic research since inception.
Support AVR
Your support helps drive real progress in eye health.
Whether through donations, leaving a bequest, or partnering with us directly, your contribution accelerates the discovery of new treatments and better outcomes for people with vision impairment.
Back vision research that will change lives.
We’re driving breakthroughs in eye health, and your support makes it possible.